Stays of District Court Litigation Pending Appeal of IPR Decisions

by Dennis Crouch

The America Invents Act (AIA) created a delicate dance between district court litigation and inter partes review (IPR) proceedings.  Patent owners often race to reach trial before the PTAB rules on validity, while accused infringers typically seek stays pending IPR. The one-year statutory deadline for IPR final written decisions provides some comfort to district courts considering stays - the delay, while substantial, is at least bounded. But what was initially conceived as a streamlined alternative to litigation has evolved into a potentially years-long process, with final written decisions now being followed by requests for USPTO Director Review and subsequent Federal Circuit appeals. This timeline extension puts courts in a difficult position when considering stays, particularly late in district court proceedings.

A recent mandamus petition highlights this tension. In In re Viasat, Inc., No. 2025-110 (Fed. Cir. Jan. 17, 2025), Judge Albright took the unusual step of sua sponte staying a patent case just days before trial in a case that had completed its IPR review and was instead awaiting Federal Circuit's appellate review. The IPR decision had cancelled some of the asserted claims, but left Claim 16 as untouched - and the patent challenger appealed to the Federal Circuit.  The patentee then narrowed the litigation to focus only on that sole remaining claim and asked the court to proceed with trial. The Federal Circuit has now declined to disturb that stay through mandamus.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

The Extraterritorial Reach of Trade Secret Law

by Dennis Crouch

A new petition for certiorari asks the Supreme Court to resolve a critical question about the global reach of U.S. trade secret law: Does the Defend Trade Secrets Act (DTSA) allow American companies to recover damages for trade secret misappropriation that occurs outside the United States? The case, Hytera Communications Corp. v. Motorola Solutions, Inc., stems from a massive jury verdict against Chinese radio manufacturer Hytera for stealing Motorola's trade secrets and source code.  [Read the Petition]. The district court awarded damages for both copyright infringement and trade secret misappropriation -- with most of the money coming from Hytera's foreign sales.  On appeal, the Seventh Circuit split on the two forms of IP - finding that the non-us-originated damages were fine for DTSA violations, but prohibited under U.S. Copyright law. Hytera petitioned to the Supreme Court only on the DTSA issue.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Federal Circuit’s Filing Requirements: A Trap for Even the Experts

By Dennis Crouch

The Federal Circuit has earned a reputation as the most technically demanding appellate court in the federal system when it comes to procedural compliance. I regularly review federal court dockets and continue to be astounded by the prevalence of filing errors and subsequent correction requirements in Federal Circuit appeals - even among the nation's most sophisticated appellate practitioners. The situation has become so routine that finding a Federal Circuit appeal without at least one notice of non-compliance is more noteworthy than finding one with multiple filing corrections.  The court's exacting standards create a procedural gauntlet that seems designed to catch all but the most careful attorneys willing to check in with the clerks office before each filing.  Although I have not done a comprehensive study, my experience is that the Federal Circuit clerk's office rejects filings as non-compliant much much more often than any other Circuit Court of Appeal.

In 2023 the Federal Circuit Clerk's Office issued a memo detailing "Common Filing Errors" - apparently recognizing the scope of the problem and attempting to push the responsibility onto the filers. However, the practitioners continue to demonstrate the exact same errors as those cited in the memo. It's as if many folks didn't get the memo - quite literally. That said, given the consistently high caliber of counsel involved and the monetary importance of these appeals, a substantial part of the difficulty may well lie with the clerk's office's approach rather than with the practitioners.

Let's examine some particularly telling examples:


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

The Inviolable Nature of Jury Verdicts

by Dennis Crouch

A new petition for certiorari filed by Provisur Technologies challenges the Federal Circuit's approach to reviewing jury verdicts in patent cases, particularly regarding willful infringement findings.  In its opinion, the Federal Circuit had rejected a jury verdict of willful infringement and the judge's resulting damages enhancement.  The petition argues that this is an improper reexamination of the jury's factual findings and a violation of the JMOL standard. Provisur v. Weber, No. 24-723.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

USPTO AI Strategy

by Dennis Crouch

The USPTO's new AI Strategy document both recounts the work the USPTO has already done and sets forth something of a vision for artificial intelligence.  Of course the document's release just one week before the transition to the Trump administration raises questions about its ultimate implementation. Time will tell whether the document is shelved, substantially modified, or implemented as written.

I wanted to take a look at a few of the biggest developments affecting day-to-day patent law practice.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Publications Before Publishing and the Federal Circuit’s Temporal Gymnastics

by Dennis Crouch

Back in October 2024, I previewed the Federal Circuit case of Lynk Labs v. Samsung in a post titled Secret Springing Prior Art and Inter Partes Review.  The court has now released its decision -- holding that in IPR proceedings a published patent application is considered prior art as of its filing date. [Read it here] This solidifies the approach already taken by the USPTO and is significant because a substantial percentage of references relied upon to cancel patent rights represent "secret prior art" that were non-public at the time the patent was originally filed. The court's analysis delves deep into statutory interpretation, legislative history, and the balance between different sections of patent law.  Unfortunately, the Judge Prost opinion is almost unintelligible at its most critical point - where it explains how the legal term "printed publication" is date agnostic.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Federal Circuit: State Law Conversion Claim Preempted Where Pleading Seeks Patent-Like Protection

On January 13, 2025, the Federal Circuit issued a notable opinion on federal preemption of state law conversion (theft) claims and correction of inventorship. In BearBox LLC v. Lancium LLC, No. 2023-1922 (Fed. Cir. Jan. 13, 2025), the court affirmed the District of Delaware’s grant of summary judgment, holding that federal patent law preempted BearBox’s Louisiana state law conversion claim. The court also affirmed that BearBox failed to prove by clear and convincing evidence that Austin Storms should be listed as an inventor of U.S. Patent No. 10,608,433.

The dispute arose from a chance encounter at a Bitcoin mining conference in May 2019. After a brief conversation at cocktail hour and dinner between BearBox’s founder Austin Storms and Lancium’s co-founder Michael McNamara, Storms sent a single follow-up email with four attachments describing BearBox’s technology. Five months later, in October 2019, Lancium filed a patent application that ultimately issued as the ‘433 patent, naming McNamara and Raymond Cline as inventors, but not Storms. (Claim 1 is listed below). The patent covered methods and systems for adjusting power consumption based on power option agreements – a concept that BearBox claimed Storms had conceived and shared with Lancium at the conference. BearBox sued, asserting both correction of inventorship under federal patent law and conversion under Louisiana state law.

State Law Preemption: The preemption issue presents an important question about the intersection of state tort law and federal patent protection. While state law conversion claims are not automatically preempted by federal patent law, the Federal Circuit found that BearBox’s particular claim as pled sought “patent-like protection” for unpatented technology and thus ran afoul of longstanding Supreme Court precedent. The court relied heavily on Bonito Boats, Inc. v. Thunder Craft Boats, Inc., 489 U.S. 141 (1989), which held that states may not offer patent-like protection to intellectual creations that would otherwise remain unprotected under federal law. The Bonito Boats Court emphasized that “the efficient operation of the federal patent system depends upon substantially free trade in publicly known, unpatented design and utilitarian conceptions.”

The Federal Circuit’s analysis focused on how BearBox pled its conversion claim, rather than the abstract elements of Louisiana conversion law. The court noted that BearBox’s complaint was “replete with ‘patent-like’ language typically invoked when a party asserts inventorship or infringement of a patent.” This included allegations that Storms had “conceived, developed, and reduced to practice” the technology and that Lancium had engaged in “improper and unauthorized use.” The prayer for relief seeking damages based on Lancium’s use and monetization of the technology particularly troubled the court, as it effectively sought patent-like remedies.  Ultimately, the court concluded:

Here, we agree with the district court that BearBox’s conversion claim is preempted because the conversion claim, as pled, is essentially an inventorship cause of action and patent infringement cause of action, and thus seeks “patent-like protection” for ideas that are unprotected under federal law.

The court distinguished this case from situations where state law claims might validly protect against misappropriation without conflicting with federal patent policy. For instance, trade secret claims often survive preemption analysis, as the Supreme Court recognized in Kewanee Oil Co. v. Bicron Corp., 416 U.S. 470 (1974). But here, BearBox’s technology was neither patented nor kept as a trade secret – instead, it was “freely shared with others” and “otherwise in the public domain.” The Federal Circuit emphasized that federal patent law generally precludes recovery for a defendant’s use of an unpatented discovery after the plaintiff makes it publicly available.*

What particularly doomed BearBox’s conversion claim was its attempt to recover damages analogous to patent remedies. The court noted that under Louisiana conversion law, damages are typically limited to return of the converted property or its value at the time of conversion. But BearBox sought ongoing royalties and lost profits – remedies that mirror 35 U.S.C. § 284’s provision for patent infringement damages. As the court explained, allowing such recovery would effectively grant BearBox patent-like control over technology it had freely disclosed, undermining Congress’s careful balance between innovation incentives and public access to ideas.

In my view, this decision is somewhat dangerous because of its potential to undermine state law cases that have protected individuals in idea-submission scenarios. Courts have long recognized claims where someone provides an idea to a company and seeks compensation when the company uses it without permission or payment These are typically tied into breach of (implied) contract or misappropriation as part of a confidential relationship. See, Desny v. Wilder, 46 Cal. 2d 715 (1956); Hoeltke v. C.M. Kemp Mfg. Co., 80 F.2d 912 (4th Cir. 1935); Aronson v. Quick Point Pencil Co., 440 U.S. 257 (1979).   In Aronson, the Court upheld a contract requiring payment for use of an invention even after a patent application was rejected, distinguishing this from state law protection that would prevent others from using publicly available information.  See also Softel, Inc. v. Dragon Med. & Sci. Communs., 118 F.3d 955 (2nd Cir. 1997); Nadel v. Play-By-Play Toys & Novelties, Inc., 208 F.3d 368 (2nd Cir. 2000).

* I want to note one procedural oddity here.  The appellate court based its decision here at least partially on the factual finding that the technology here was not kept secret but instead had been “freely shared with others” and “otherwise in the public domain.”  The district court made those conclusions following the bench trial on inventorship.  But, the those facts were still in contention at the summary judgment stage when the district court decided the preemption issue.  And, normally an appellate court reviews the summary judgment record independently, applying the same standards as the district court to determine whether summary judgment was appropriate. This issue probably deserves some additional research, but it is not clear to me that the court appropriately relied upon the publicly-available status of the submissions in its review of the summary judgment.

Inventorship Claims Fail Due to Lack of Clear and Convincing Evidence

Apart from the state law claim, BearBox also claimed inventorship rights under 35 U.S.C. § 256.  That statute provides a court with authority to order correction of inventorship when it determines an inventor has been erroneously omitted from a patent. However, patent issuance creates a presumption that the named inventors are the true and only inventors, and the late-coming inventor faces the heavy burden of proving inventorship by clear and convincing evidence.

A key challenge for BearBox was the requirement that an alleged joint inventor’s testimony must be corroborated by independent evidence. As the Federal Circuit has long held, “an alleged co-inventor must supply evidence to corroborate his testimony.” Ethicon, Inc. v. U.S. Surgical Corp., 135 F.3d 1456 (Fed. Cir. 1998). While corroborating evidence can take various forms – including contemporaneous documents, physical evidence, circumstantial evidence about the inventive process, or testimony from others – BearBox’s case rested primarily on four attachments sent in a single email: a product specification sheet, an annotated system diagram, hardware component specifications, and a data file modeling system simulation.

The district court’s analysis, which the Federal Circuit affirmed, found these materials insufficient to establish Storms’ inventorship claims. First, Storms himself admitted that the hardware component specifications had nothing to do with the subject matter of the ‘433 patent. More fundamentally, for the remaining documents, BearBox could not establish either that Storms had conceived of the claimed invention or that he had communicated any relevant information prior to Lancium’s independent conception.  This timing issue proved particularly problematic because Lancium had filed a prior patent application in February 2018 – fifteen months before Storms ever met anyone from Lancium – disclosing many key aspects of the technology.

To qualify as a joint inventor, an individual must “show that he contributed significantly to the conception—the definite and permanent idea of the invention—or reduction to practice of at least one claim.” Blue Gentian, LLC v. Tristar Prod., Inc., 70 F.4th 1351 (Fed. Cir. 2023). These contributions must arise from “some element of joint behavior, such as collaboration or working under common direction.” Kimberly-Clark Corp. v. Procter & Gamble Distrib. Co., Inc., 973 F.2d 911 (Fed. Cir. 1992). The Federal Circuit found no error in the district court’s conclusion that the limited interaction between Storms and Lancium – essentially one dinner conversation and a single email – failed to establish the required level of collaboration or significant contribution to conception.

BearBox raised several procedural challenges to the district court’s inventorship analysis, but none proved persuasive. The Federal Circuit rejected BearBox’s argument that the district court improperly excluded as hearsay Storms’ testimony about what he told McNamara at dinner. While acknowledging some merit to the argument that the testimony was offered for a non-hearsay purpose (to prove notice rather than truth), the court found that BearBox’s failure to make an offer of proof about what the testimony would have been was “fatal” to preserving the issue for appeal.

The Federal Circuit also dismissed BearBox’s criticism of the district court’s element-by-element analysis of the patent claims.  At oral arguments BearBox’s counsel argued:

All claims, or maybe most, the majority of claims, are a combination of known elements. And so, if the District Court is looking at the elements in isolation for evidence of earlier conception or conception, it will always be found.

While BearBox argued that the court should have considered claim elements in combination, the Federal Circuit found no error in the limitation-by-limitation approach given that BearBox needed to demonstrate Storms’ significant contribution to at least one claim. The court noted that this analysis actually mirrored how BearBox itself had presented its case in post-trial briefing.

= = =

The appellate panel also affirmed the district court’s exclusion of Dr. McClellan’s supplemental expert report, which had been filed three weeks before trial and five months after the close of expert discovery.

= = =

The Federal Circuit panel consisted of Judges Chen, Bryson, and Stoll, with Judge Stoll writing the opinion. The case was appealed from the District of Delaware where Judge Williams presided. Benjamin Horton argued the case for BearBox who was also represented by John Labbe, Chelsea Murray, and Raymond Ricordati of Marshall Gerstein. Mark Nelson argued for Lancium and was joined on the brief by other Barnes & Thornburg lawyers, including Adam Kaufmann and Chad Stover.

= = =

Claim 1. A system comprising:

a set of computing systems, wherein the set of computing systems is configured to perform computational operations using power from a power grid;

a control system configured to:

monitor a set of conditions;

receive power option data based, at least in part, on a power option agreement, wherein the power option data specify: (i) a set of minimum power thresholds, and (ii) a set of time intervals, wherein each minimum power threshold in the set of minimum power thresholds is associated with a time interval in the set of time intervals;

responsive to receiving the power option data, determine a performance strategy for the set of computing systems based on a combination of at least a portion of the power option data and at least one condition in the set of conditions, wherein the performance strategy comprises a power consumption target for the set of computing systems for each time interval in the set of time intervals, wherein each power consumption target is equal to or greater than the minimum power threshold associated with each time interval; and

provide instructions to the set of computing systems to perform one or more computational operations based on the performance strategy.

Supreme Court Asked to Expand Fee Recovery in Patent Cases: Can Courts Make Attorneys Pay and What about IPR Fees??

Dennis Crouch

In a newly filed petition for certiorari, DISH Network has asked the Supreme Court to resolve two important questions about attorney fee awards in patent cases: whether district courts can (1) make plaintiff's attorneys jointly liable for fee awards in exceptional cases and (2) award fees incurred during parallel Inter Partes Review (IPR) proceedings. DISH Network L.L.C. v. Dragon Intellectual Property, LLC, No. 24-726 (petition filed Jan. 8, 2025).


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Federal Circuit Rejects Invalidation Based on After-Arising Technology

by Dennis Crouch

In an important opinion exploring the relationship between patent validity and after-arising technology, the Federal Circuit has reversed a district court's invalidation of a pharmaceutical patent covering Novartis's blockbuster heart failure drug Entresto. Novartis Pharmaceuticals Corp. v. Torrent Pharma Inc., Nos. 2023-2218, 2023-2220, 2023-2221 (Fed. Cir. Jan. 10, 2025).


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Federal Circuit: Pink Hip Implants Are Functional, Cannot Be Protected as Trade Dress

by Dennis Crouch

The Federal Circuit has affirmed the Trademark Trial and Appeal Board (TTAB) cancellation of CeramTec's trademark registrations for the pink color of its ceramic hip implants, and also providing an important analysis of functionality doctrine and its intersection with expired utility patents. CeramTec GmbH v. CoorsTek Bioceramics LLC, No. 2023-1502 (Fed. Cir. Jan. 3, 2024).  The cautionary outcome here is unsubstantiated statements in the utility patent left the patentee unable to later claim trade dress protection for the distinctive feature.  Patent attorneys should consider a trade dress discussion with their clients prior to filing a utility application that covers potentially distinctive trade dress. I discussed the case while it was pending. See Dennis Crouch, Pink Ceramic Hip Implants: When Functionality Trumps Trade Dress, Patently-O (October 2024).


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Patent Term Adjustments Cut by Applicant Delays: A 23,000 Year Impact

by Dennis Crouch

The Patent Term Adjustment (PTA) statute was designed to ensure patent terms aren't unfairly shortened by USPTO delays during prosecution. 35 U.S.C. § 154(b). The basic framework provides day-for-day extension of patent term to account for certain examination delays, such as when the USPTO takes more than 14 months to issue a first office action or more than 4 months to respond to an applicant's reply.

But PTA is a two-way street. The statute also penalizes applicants who fail to "engage in reasonable efforts to conclude processing or examination." 35 U.S.C. § 154(b)(2)(C). The most common applicant delay comes from taking more than three months to respond to an office action. See 37 C.F.R. § 1.704(b).


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Not Quite Teaching Away: Federal Circuit Clarifies Evidence Needed to Defeat Motivation to Combine

by Dennis Crouch

In a recent non-precedential decision, the Federal Circuit provided an interesting analysis on how to evaluate evidence both supporting and undermining motivation to combine references in obviousness challenges. Laboratory Corporation of America Holdings v. Ravgen, Inc., No. 2023-1342, 2023-1345 (Fed. Cir. Jan. 6, 2025).


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Ripe for Review: Digital Access to a Banana taped to the Wall

by Dennis Crouch

Let me peel back the layers of this slippery copyright dispute that has the art world going bananas. In Morford v. Cattelan, No. 23-12263 (11th Cir. 2024), the Eleventh Circuit confronted the question of whether an artist can claim copyright protection over the concept of taping a banana to a wall. The appellate court sided with the accused famous artist, Morford continues to pursue his copyright action in a newly filed petition for writ of certiorari to the Supreme Court.

(more…)

Patents as Product Liability Admissions: A Cert Petition Highlights Novel Use of Patent Filings in Whistleblower Case

by Dennis Crouch

A fascinating cert petition filed last week (Peterson v. Minerva Surgical) uses Minerva’s patents in an innovative way — attempting to use the company’s patent filings as evidence of prior knowledge of product safety issues. The petition, filed by former Minerva Surgical area sales director Dan Peterson, argues that the company’s patent application for an improved surgical device directly contradicted testimony it later gave in whistleblower retaliation arbitration proceedings.

According to the petition, in January 2017, Minerva filed Patent Application No. 15/418,635 seeking protection for a modified endometrial ablation device. The application disclosed that the original design had a defect that could “plug” uterine perforations, potentially leading to serious patient injuries. The USPTO ultimately granted the patent (No. 10,213,151) in February 2019, with claims explicitly discussing how the new design solved these safety issues. (more…)

Federal Circuit Internal Debate over Reversal versus Vacatur

by Dennis Crouch

Yesterday, the Federal Circuit issued a divided opinion in Honeywell International Inc. v. 3G Licensing, S.A., No. 2023-1354 (Fed. Cir. Jan. 2, 2025), highlighting key disagreements about the proper role of appellate courts in reviewing Patent Trial and Appeal Board (PTAB) decisions.  The case appears to also foreshadow an internal fight over the exclusion of expert testimony that is currently pending en banc in EcoFactor v. Google.

The case centers on the validity of a patent related to encoding data in cellular communications, specifically focusing on methods for protecting important data bits from transmission errors.  Patent No. 7,319,718.  Writing for the majority, Judge Dyk reversed the PTAB's holding that the claims were not proven obvious. Judge Stoll write in dissent, arguing the majority improperly stepped into the role of fact-finder rather than acting as an appellate tribunal.  To be clear, Judge Stoll was no fan of the PTAB's opinion, but would have vacated and remanded for further factual development on the question of obviousness rather than entirely flipping the decision via reversal.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Supreme Court Preview: Will “Skinny Labels” Get a Weight Check?

by Dennis Crouch

The Supreme Court will soon be asked to weigh in on the the skinny-label debate -- particularly the question of how much a generic drug manufacturers can say about their products without inducing patent infringement? The case is Hikma v. Amarin.

It is very common for a drug to follow the following innovation-patent pathway:

  1. First the composition is discovered and patented along with a particular therapeutic use.
  2. Later a more effective treatment regimen is discovered and patented.

Once the first set of patents expire, generic manufactures should be permitted to begin marketing the drug -- except for uses still patented.  But, this gets tricky.  We know that there will be a very $trong incentive for insurance companies, doctors, and patients to use the cheaper generic drug for the still-patented treatment regime.  The question is whether the generic manufacture can be blamed for inducing this infringement.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Patent Grants for 2024

by Dennis Crouch

For decades the USPTO has issued patents each and every Tuesday -- with data being released typically at 12:01 a.m. Eastern time.  Today's release wraps up 2024 and almost breaks a record with 7,499 utility patents issued -- the second most ever in any given week.  (The #1 spot is held by 7669 utility patents issued on October 3, 2023).  The total UTL patents issued has been rising for the past several years but are still below the 2019 high point at over 350,000.

As you look at the chart above, the 2024 patent count numbers are a bit skewed upward because of a calendaring quirk. While most years have 52 Tuesdays, 2024 has 53 Tuesdays. This extra Tuesday means the USPTO has one additional patent issue day compared to a typical year, which represents roughly a 2% increase in opportunities for patent grants over the calendar year.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.